{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:27:02Z","timestamp":1777487222246,"version":"3.51.4"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T00:00:00Z","timestamp":1752364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fractures and pseudofractures cause considerable morbidity in adults with X-linked hypophosphatemia (XLH). They frequently occur in cortically-enriched bones of the lower extremities. Burosumab, a neutralizing antibody to FGF23, heals fractures in adults with XLH, presumably by healing osteomalacia. Histomorphometry has documented healing of osteomalacia in trabecular bone. The effects of burosumab on cortical bone have not been reported. Therefore, 3D-DXA measurements of the proximal femur were used to examine the impact of 1\u00a0yr of burosumab therapy on cortical and trabecular bone in symptomatic adults with XLH. Twenty volunteers from the registration trial for burosumab were separately consented for this study. DXA scans of the hip were obtained before and 6, 12, and 18-24\u00a0mo after drug therapy (1\u00a0mg\/kg every 4 wk). 3D-DXA analyses were performed using 3D-Shaper software (3D-Shaper Medical). Changes in FN areal BMD (aBMD), TH aBMD, TH trabecular volumetric BMD (vBMD), FN trabecular vBMD, TH cortical surface BMD (sBMD), FN cortical sBMD, and FN cross-sectional moment of inertia (CSMI) were analyzed. Both TH and FN trabecular vBMD showed significant increases over the course of therapy (13.6% and 14.1% respectively at the end of treatment compared to baseline; p\u2009&amp;lt;\u2009.0001 for each). Fractures and pseudofractures often occur in the cortically-enriched FN in XLH. Burosumab induced a significant increase in FN cortical sBMD between 6 and 12 mo (p\u2009&amp;lt;\u2009.05) and between 6 and 18-24 mo of drug treatment (p\u2009&amp;lt;\u2009.05). The FN CSMI, an indicator of FN strength, also significantly increased at 12 and 18-24 mo when compared to baseline; p\u2009&amp;lt;\u2009.05 and p\u2009&amp;lt;\u2009.01, respectively. These data demonstrate that burosumab increases both cortical and trabecular bone in the hip, a site of frequent fracture in XLH.<\/jats:p>","DOI":"10.1093\/jbmr\/zjaf092","type":"journal-article","created":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T03:48:11Z","timestamp":1752378491000},"page":"1343-1350","source":"Crossref","is-referenced-by-count":2,"title":["3D-DXA reveals significant effects of burosumab on trabecular and cortical skeletal envelopes in symptomatic adults with X-linked hypophosphatemia"],"prefix":"10.1093","volume":"40","author":[{"given":"Rucha","family":"Patki","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Section of Endocrinology, Yale School of Medicine , New Haven, CT 06510 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-6768","authenticated-orcid":false,"given":"Thomas","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Endocrinology, Yale School of Medicine , New Haven, CT 06510 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keerti","family":"Murari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Endocrinology, Yale School of Medicine , New Haven, CT 06520 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5074-1822","authenticated-orcid":false,"given":"Stephen","family":"Parziale","sequence":"additional","affiliation":[{"name":"Yale Center for Analytical Sciences, Yale School of Public Health , New Haven, CT 06510 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-468X","authenticated-orcid":false,"given":"Yanhong","family":"Deng","sequence":"additional","affiliation":[{"name":"Yale Center for Analytical Sciences, Yale School of Public Health , New Haven, CT 06510 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Humbert","sequence":"additional","affiliation":[{"name":"3D-Shaper Medical , Rambla Catalunya 53, 4\u00ba-H08007 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella Lopez","family":"Picazo","sequence":"additional","affiliation":[{"name":"3D-Shaper Medical , Rambla Catalunya 53, 4\u00ba-H08007 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-5679","authenticated-orcid":false,"given":"Karl L","family":"Insogna","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Endocrinology, Yale School of Medicine , New Haven, CT 06520 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,13]]},"reference":[{"issue":"5","key":"2025120900311727900_ref1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00198-017-3949-8","article-title":"Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets","volume":"28","author":"Colares Neto","year":"2017","journal-title":"Osteoporos Int"},{"issue":"2","key":"2025120900311727900_ref2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","article-title":"Phenotype presentation of hypophosphatemic rickets in adults","volume":"87","author":"Beck-Nielsen","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2025120900311727900_ref3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/jbmr.3955","article-title":"X-linked hypophosphatemia: uniquely mild disease associated with PHEX 3'-UTR mutation c.*231A&gt;G (a retrospective case-control study)","volume":"35","author":"Smith","year":"2020","journal-title":"J Bone Miner Res"},{"key":"2025120900311727900_ref4","doi-asserted-by":"publisher","first-page":"117179","DOI":"10.1016\/j.bone.2024.117179","article-title":"Evaluation of bone density and microarchitecture in adult patients with X-linked hypophosphatemic rickets: a pilot longitudinal study","volume":"187","author":"Funck-Brentano","year":"2024","journal-title":"Bone"},{"issue":"1","key":"2025120900311727900_ref5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jbmr.2310","article-title":"Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with hypophosphatemic rickets","volume":"30","author":"Shanbhogue","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2025120900311727900_ref6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of Burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2025120900311727900_ref7","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jbmr.3843","article-title":"Burosumab improved Histomorphometric measures of Osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial","volume":"34","author":"Insogna","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025120900311727900_ref8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0221-8747(81)90002-3","article-title":"Stimulation of cortical bone mineralization and remodeling by phosphate and 1,25-dihydroxyvitamin D in vitamin D-resistant rickets","volume":"3","author":"Marie","year":"1981","journal-title":"Metab Bone Dis Relat Res"},{"issue":"9","key":"2025120900311727900_ref9","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/jbmr.4641","article-title":"Bone matrix mineralization and response to Burosumab in adult patients with X-linked hypophosphatemia: results from the phase 3, single-arm international trial","volume":"37","author":"Fratzl-Zelman","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"2025120900311727900_ref10","doi-asserted-by":"publisher","first-page":"Abstract #: SUN_333","DOI":"10.1210\/jendso\/bvaa046.1470","article-title":"Burosumab improves bone density in patients with X-linked hypophosphatemia","volume":"4","author":"Murari","year":"2020","journal-title":"J Endocr Soc"},{"issue":"1","key":"2025120900311727900_ref11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1109\/TMI.2016.2593346","article-title":"3D-DXA: assessing the femoral shape, the trabecular macrostructure and the cortex in 3D from DXA images","volume":"36","author":"Humbert","year":"2017","journal-title":"IEEE Trans Med Imaging"},{"issue":"12","key":"2025120900311727900_ref12","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1109\/TMI.2018.2845909","article-title":"3-D subject-specific shape and density estimation of the lumbar spine from a single anteroposterior DXA image including assessment of cortical and trabecular bone","volume":"37","author":"Lopez Picazo","year":"2018","journal-title":"IEEE Trans Med Imaging"},{"issue":"4","key":"2025120900311727900_ref13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/jbmr\/zjae028","article-title":"3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate","volume":"39","author":"Lewiecki","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025120900311727900_ref14","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1118\/1.4944501","article-title":"Technical note: cortical thickness and density estimation from clinical CT using a prior thickness-density relationship","volume":"43","author":"Humbert","year":"2016","journal-title":"Med Phys"},{"issue":"4","key":"2025120900311727900_ref15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jocd.2017.05.002","article-title":"Structural parameters of the proximal femur by 3-dimensional dual-energy X-ray absorptiometry software: comparison with quantitative computed tomography","volume":"21","author":"Clotet","year":"2018","journal-title":"J Clin Densitom"},{"issue":"Suppl 1","key":"2025120900311727900_ref16","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1007\/BF01673401","article-title":"Age-related changes in female femoral neck geometry: implications for bone strength","volume":"53","author":"Beck","year":"1993","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2025120900311727900_ref17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s40265-018-0905-7","article-title":"Burosumab: first global approval","volume":"78","author":"Lamb","year":"2018","journal-title":"Drugs"},{"issue":"10189","key":"2025120900311727900_ref18","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"2025120900311727900_ref19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued beneficial effects of Burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2025120900311727900_ref20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1210\/clinem\/dgac518","article-title":"Long-term Burosumab administration is safe and effective in adults with X-linked hypophosphatemia","volume":"108","author":"Weber","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025120900311727900_ref21","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025120900311727900_ref22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/BF02553698","article-title":"Bone mineral content of the femoral neck and shaft: relation between cortical and trabecular bone","volume":"37","author":"Bohr","year":"1985","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2025120900311727900_ref23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1359\/jbmr.081108","article-title":"Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength","volume":"24","author":"Holzer","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2025120900311727900_ref24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00004424-199702000-00002","article-title":"Distribution of trabecular and cortical bone related to geometry. A quantitative computed tomography study of the femoral neck","volume":"32","author":"Kuiper","year":"1997","journal-title":"Investig Radiol"},{"issue":"5","key":"2025120900311727900_ref25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jbiomech.2014.12.022","article-title":"Cortical and trabecular load sharing in the human femoral neck","volume":"48","author":"Nawathe","year":"2015","journal-title":"J Biomech"},{"issue":"3","key":"2025120900311727900_ref26","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1210\/clinem\/dgab739","article-title":"Musculoskeletal features in adults with X-linked hypophosphatemia: an analysis of clinical trial and survey data","volume":"107","author":"Javaid","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025120900311727900_ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052500","article-title":"Fibroblast growth factor 23 and osteoporosis: evidence from bench to bedside","volume":"23","author":"Sirikul","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2025120900311727900_ref28","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.media.2012.02.008","article-title":"Imaging the femoral cortex: thickness, density and mass from clinical CT","volume":"16","author":"Treece","year":"2012","journal-title":"Med Image Anal"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjaf092\/63735922\/zjaf092.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/40\/12\/1343\/63735922\/zjaf092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/40\/12\/1343\/63735922\/zjaf092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:31:35Z","timestamp":1765258295000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/40\/12\/1343\/8198096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,13]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,7,13]]},"published-print":{"date-parts":[[2025,11,29]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjaf092","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,7,13]]}}}